The story goes like this: At a 1976 Biophysical Society meeting, Erwin Neher presented the technique that would win a Nobel Prize for him and Bert Sakmann.
Since 1998, when 18-year-old Jesse Gelsinger died in a clinical trial at the University of Pennsylvania, the news on gene therapy hasn't gotten much better.
The tally is grim: three high-profile cancer cases, including one death, in French boys who underwent pioneering gene therapy for X-linked severe combined immunodeficiency (X-SCID).
only 31 of every 100 human conceptions complete the journey.
is one usually met with utter dread.
The biggest news these days in tissue microarrays (TMAs) may be that this former "next big thing" has become a standard tool for molecular profiling of disease.
hler, two researchers at the Medical Research Council's (MRC) Laboratory of Molecular Biology in Cambridge, were investigating the mechanisms underlying the remarkable diversity of antibodies.
In 1895 two French physicians attempted a radical departure from the standard cancer treatment regimen.
In terms of innovation, the life science industry has few peers.